Your Search for 'CNS Generic Drugs: Prospects and Opportunities to 2012' returned 5 results - Page 1 of 1

• Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech

  EURO€ 1,922.00USD$ 2,500.00GBP£ 1,617.00AUD$ 2,445.00JPY¥ 246,832.00SEK 16 415,00CHF 2'356.00CAD$ 2,547.00 MP Advisors, Jan 2013 , Pages: 110
  driven by launch of Innovative drugs catering to unmet needs in Alzheimer’s, HCV, osteoporosis, RA, Psoriasis, MS, Dyslipidemia, Cystic fibrosis, Cancer and orphan diseases. Drug approvals and label ...

• Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012

  EURO€ 1,192.00USD$ 1,347.00GBP£ 795.00AUD$ 1,863.00JPY¥ 161,585.00SEK 10 600,00CHF 1'775.00CAD$ 1,728.00 Spectra Intelligence, Nov 2005 , Pages: 91
  . In this report, Psychopharmacotherapy Market Insights: Obstacles and Opportunities in Mood Disorders and Cognitive Impairment, 2005-2012, the reader will be introduced to CNS therapy areas of ...

• Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs 2010

  EURO€ 1,620.00USD$ 2,108.00GBP£ 1,363.00AUD$ 2,061.00JPY¥ 208,087.00SEK 13 838,00CHF 1'986.00CAD$ 2,148.00 Espicom Business Intelligence Ltd, Mar 2010 , Pages: 128
  . Among her reports are the first edition of this report, plus Injectable Generic Drugs: Prospects and Opportunities to 2014 Emerging Opportunities in Controlled-Release Generic Drugs Diabetes Drug ...

• Lupin Limited (LUPIN) - Financial and Strategic SWOT Analysis Review

  EURO€ 96.00USD$ 125.00GBP£ 81.00AUD$ 122.00JPY¥ 12,342.00SEK 821,00CHF 118.00CAD$ 127.00 GlobalData, Apr 2013 , Pages: 41
  branded drugs, formulations and active pharmaceutical ingredients (API’s). The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatric, GI, CNS, anti-infective, NSAID, Anti-TB ...

• Teva Pharmaceutical Industries Limited (TEVA) - Financial and Strategic SWOT Analysis Review

  EURO€ 96.00USD$ 125.00GBP£ 81.00AUD$ 122.00JPY¥ 12,342.00SEK 821,00CHF 118.00CAD$ 127.00 GlobalData, Apr 2013 , Pages: 62
  operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives ...